Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial. [electronic resource]
Producer: 20141215Description: 997-1006 p. digitalISSN:- 1474-5488
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Density Conservation Agents -- therapeutic use
- Breast Neoplasms -- drug therapy
- Chemotherapy, Adjuvant
- Confidence Intervals
- Diphosphonates -- therapeutic use
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Early Detection of Cancer
- Female
- Follow-Up Studies
- Humans
- Imidazoles -- therapeutic use
- Infusions, Intravenous
- International Cooperation
- Kaplan-Meier Estimate
- Middle Aged
- Neoplasm Invasiveness -- pathology
- Neoplasm Staging
- Prospective Studies
- Survival Rate
- Treatment Outcome
- Zoledronic Acid
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.